A connective tissue disorder is any condition that damages the proteins and structures holding your body together. Connective tissue is the scaffolding that supports your skin, bones, blood vessels, joints, and organs, so when something goes wrong with it, the effects can show up almost anywhere. There are over 200 recognized connective tissue disorders, ranging from genetic conditions you’re born with to autoimmune diseases that develop later in life.
What Connective Tissue Actually Does
Connective tissue is one of the most widespread materials in your body. It’s made of three components: protein fibers (mainly collagen and elastin), a gel-like filler called ground substance, and various cells that maintain and repair everything. Collagen provides tensile strength, the kind of toughness that keeps a ligament from snapping when you twist your ankle. Elastin gives tissues their ability to stretch and bounce back, like the walls of your blood vessels expanding with each heartbeat.
This tissue takes many forms depending on where it is. Bone is connective tissue hardened by mineral deposits. Cartilage is a smoother, more flexible version that cushions your joints. Tendons and ligaments are dense bundles of collagen fibers arranged in parallel rows for maximum strength. Even the deep layer of your skin is connective tissue. Because it’s so fundamental, a disorder affecting connective tissue rarely stays confined to one part of the body.
Genetic vs. Autoimmune Types
Connective tissue disorders fall into two broad categories: those caused by faulty genes and those caused by an immune system attacking healthy tissue.
Genetic (heritable) disorders result from mutations in genes that code for structural proteins. These conditions are present from birth, though symptoms may not become obvious until childhood or adolescence. The major ones include:
- Ehlers-Danlos syndrome (EDS): A group of conditions affecting collagen. In the classical type, mutations in the COL5A1 gene (over 100 different mutations have been identified) reduce the amount of a key collagen building block that cells produce. The result is disorganized, oversized collagen fibers in the skin and other tissues, leading to stretchy skin, fragile tissue, and joints that bend far beyond their normal range.
- Marfan syndrome: Caused by mutations in the FBN1 gene, which alter the composition of the structural matrix surrounding cells. People with Marfan syndrome are often tall and long-limbed, with a heightened risk of aortic problems because the connective tissue in blood vessel walls is weaker than normal.
- Osteogenesis imperfecta: Sometimes called brittle bone disease, this affects collagen in bones, making them fracture easily even from minor impacts.
Autoimmune disorders develop when the immune system mistakenly targets connective tissue as though it were a foreign invader. These typically emerge in adulthood and can fluctuate between flares and periods of relative calm. The most well-known include lupus, which can affect the skin, joints, kidneys, and brain, and scleroderma, which causes hardening and tightening of the skin and internal organs. Mixed connective tissue disease (MCTD) is a condition that overlaps features of lupus, scleroderma, and other autoimmune disorders.
Common Symptoms Across Disorders
Because connective tissue is everywhere, symptoms depend heavily on which type you have and which tissues are most affected. That said, certain patterns recur across many of these conditions.
Joint problems are among the most common. In genetic disorders like EDS, joints may be hypermobile, bending further than they should and dislocating easily. In autoimmune types, joints are more likely to be swollen, stiff, and painful, resembling rheumatoid arthritis. Skin changes are also frequent: unusually stretchy or fragile skin in EDS, a butterfly-shaped rash across the face in lupus, or thickened, tight skin in scleroderma.
Many connective tissue disorders also involve the cardiovascular system, the lungs, or the digestive tract. Raynaud’s phenomenon, where fingers and toes turn white or blue in cold temperatures due to blood vessel spasms, is especially common in autoimmune types. Fatigue that doesn’t improve with rest runs through nearly all of them.
How These Disorders Are Diagnosed
There’s no single test for all connective tissue disorders. Diagnosis usually combines a physical exam, lab work, imaging, and sometimes genetic testing.
For genetic conditions involving joint hypermobility, doctors often use the Beighton score, a nine-point physical assessment. It checks whether you can hyperextend your knees, bend your pinky fingers back past 90 degrees, touch your thumbs to your forearms, and place your palms flat on the floor with straight knees. A score of four or more on the physical maneuvers, combined with joint pain lasting at least three months, suggests hypermobility syndrome. Your doctor will also ask historical questions about your flexibility over time.
For autoimmune connective tissue diseases, blood tests play a central role. A test for antinuclear antibodies (ANAs) is typically the starting point. If that’s positive, more specific panels follow, looking for antibodies associated with particular conditions. A first-line panel often checks for antibodies linked to lupus, MCTD, and related diseases. These markers help distinguish between conditions that can look very similar on the surface.
When Marfan syndrome or vascular EDS is suspected, genetic testing can confirm mutations in specific genes. This is important not just for the individual but for screening family members who may carry the same mutation without knowing it. Imaging, such as echocardiography to measure the size of the aorta, is used to monitor cardiovascular risk in these patients.
Cardiovascular Risks in Genetic Types
One of the most serious complications of heritable connective tissue disorders is aortic aneurysm or dissection, where the body’s largest artery weakens, bulges, or tears. In Marfan syndrome, mutations in the FBN1 gene create a fundamental vulnerability in the aortic wall by disrupting how the structural matrix interacts with growth-signaling molecules. This makes the aorta progressively weaker over time.
Vascular Ehlers-Danlos syndrome carries a particularly high risk for aortic fragility and arterial rupture. Because the collagen in blood vessel walls is defective, arteries can tear with little warning. Regular monitoring with echocardiography to track aortic root dimensions is a standard part of care for people with these conditions. When the aorta reaches a dangerous size, preventive surgery may be recommended before a tear occurs.
Treatment and Daily Management
Treatment varies dramatically depending on the type of disorder. There is no cure for any connective tissue disorder, but most can be managed effectively enough to maintain quality of life.
For autoimmune types, the goal is to control inflammation and prevent the immune system from damaging tissue. Mild joint pain and swelling often respond to anti-inflammatory medications. A medication originally developed to treat malaria, hydroxychloroquine, is widely used as a baseline treatment. One French study found that patients who started hydroxychloroquine early after being diagnosed with MCTD were less likely to develop lung complications later. For more aggressive disease, stronger immune-suppressing medications are used, sometimes in combination.
Raynaud’s phenomenon, which is common in autoimmune connective tissue diseases, is managed partly through careful cold avoidance and partly through medications that relax blood vessels. Digestive symptoms like acid reflux, which frequently accompanies MCTD, are treated with medications that reduce stomach acid.
For genetic disorders like EDS, treatment focuses more on protecting joints and preventing injury. Physical therapy tailored to your specific limitations is a cornerstone of care. Strengthening the muscles around hypermobile joints helps compensate for ligaments that don’t provide enough stability on their own. An active lifestyle with appropriate exercise is supported by evidence as beneficial for people with arthritis-like symptoms in connective tissue disease, though the type and intensity should match your condition.
How Common Are These Disorders
Individual connective tissue disorders are relatively rare, but taken together, the group affects a meaningful number of people. Mixed connective tissue disease, for example, occurs in roughly 2 people per 100,000 per year based on a population study from Minnesota. Prevalence estimates range from about 3 per 100,000 (counting only people with MCTD alone) to over 16 per 100,000 when including people who have MCTD alongside another connective tissue diagnosis, according to data from the Manhattan Lupus Surveillance Program. Marfan syndrome affects roughly 1 in 5,000 people, and EDS (all types combined) may be even more common, though many mild cases go undiagnosed for years.
Women are disproportionately affected by the autoimmune types. Lupus, for instance, strikes women about nine times more often than men, and MCTD also shows a strong female predominance. Genetic types affect men and women equally, since the mutations are typically inherited in patterns that don’t depend on sex.